Results 131 to 140 of about 435,346 (208)
Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias. [PDF]
NeurologyKivisäkk P, Fatima H, Wu CY, Padmanabhan N, Romero D, Gorham T, Weik M, Dodge HH, Scherzer CR, Das S, Chibnik LB, Blacker DL, Gomez-Isla T, Oakley DH, Frosch MP, Hyman BT, Demos C, Sigal G, Wohlstadter JN, Serrano-Pozo A, Arnold SE. +20 moreeuropepmc +1 more sourceCharacterization and validation of EHR computable phenotypes for Long COVID using patient-reported symptoms: insights from the nationwide RECOVER program. [PDF]
J Am Med Inform AssocCastro VM, Gainer V, Wattanasin N, Cagan A, Holzbach A, Chan J, Horwitz L, Kenney R, Diaz I, Mandel H, Wuller S, Hornig M, O'Brien L, Wylam A, Doster J, Moffitt RA, Pfaff E, Weiner MG, Abedian S, Koropsak M, Parthasarathy S, Razzaghi H, Manjourides J, Karlson EW, Murphy SN, of the RECOVER Consortium
. +25 moreeuropepmc +1 more sourceA systematic review of clinical practice guidelines and other best practice recommendations for pressure injury risk assessment in the United States. [PDF]
Wound Repair RegenSerafin A, Graziadio S, Velickovic V, Milde TC, Dinnes J, Sitch A, Coombe A, McNichol L, Armstrong DG, Lueck H, Kottner J. +10 moreeuropepmc +1 more sourceSocial Determinants of Health and Pediatric Long COVID in the US. [PDF]
JAMA PediatrRhee KE, Thaweethai T, Pant DB, Stein CR, Salisbury AL, Kinser PA, Kleinman LC, Gallagher R, Warburton D, Mohandas S, Snowden JN, Stockwell MS, Tantisira KG, Flaherman VJ, Teufel RJ, Castro L, Chung A, Espinoza Esparza J, Hockett CW, Isidoro-Chino M, Krishnan A, McCormack LA, Nabower AM, Nahin ER, Rosas JM, Siddiqui S, Szmuszkovicz JR, Vangeepuram N, Zimmerman E, Brown HE, Carmilani M, Coombs K, Fisher L, Witvliet MG, Wood JC, Milner JD, Rosenzweig EB, Irby K, Karlson EW, Qian Z, Lamendola-Essel MF, Hasson DC, Katz SD, Yin HS, Foulkes AS, Gross RS, RECOVER-Pediatrics Group; and the ABCD-RECOVER Group; for the RECOVER-Pediatrics Consortium
, Aschner JL, Atz AM, Banerjee D, Bogie A, Bukulmez H, Clouser K, Cottrell LA, Cowan K, D'Sa VA, Dozor AJ, Elliott AJ, Faustino EVS, Fiks AG, Gaur S, Gennaro ML, Gordon ST, Hasan UN, Hester CM, Hogan AH, Hsia DS, Kaelber DC, Kosut JS, Krishnan S, McCulloh RJ, Michelow IC, Nolan SM, Oliveira CR, Pace WD, Palumbo P, Raissy H, Reyes A, Ross JL, Salazar JC, Selvarangan R, Stevenson MD, Werzberger A, Westfall JM, Zani K, Zempsky WT, Chan J, Metz TD, Newburger JW, Truong DT, Feldman CH, Aupperle R, Baker FC, Banich MT, Barch DM, Baskin-Sommers A, Bjork JM, Dapretto M, Brown SA, Casey BJ, Chang L, Clark DB, Dale AM, Ernst TM, Fair DA, Feldstein Ewing SW, Foxe JJ, Freedman EG, Friedman NP, Garavan H, Gee DG, Gonzalez R, Gray KM, Heitzeg MM, Herting MM, Jacobus J, Laird AR, Larson CL, Lisdahl KM, Luciana M, Luna B, Madden PAF, McGlade EC, Müller-Oehring EM, Nagel BJ, Neale MC, Paulus MP, Potter AS, Renshaw PF, Sowell ER, Squeglia LM, Uddin LQ, Wilson S, Yurgelun-Todd DA. +133 moreeuropepmc +1 more sourcePrognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment. [PDF]
JAMABuckley RF, Townsend DL, Birkenbihl CJ, Cuppels M, Coughlan GT, Seto MT, Brown JA, Properzi MJ, Hönig MC, Li A, Schultz AP, Chhatwal J, Yang HS, Arnold S, Kivisäkk P, James BD, O'Bryant S, Rissman RA, Petersen M, Caldwell JZK, Betthauser T, Oomens JE, Carrigan M, Healy B, Condado JG, Johnson SC, Yau WW, Langford O, Farrell M, Amariglio RE, Rentz DM, Papp KV, Brookmeyer R, Hohman TJ, Donohue M, Aisen PS, Johnson KA, Sperling RA, Alzheimer’s Disease Neuroimaging Initiative, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, Harvard Aging Brain Study (HABS), Health & Aging Brain Study – Health D, Alzheimer’s Disease Neuroimaging Initiative, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, Harvard Aging Brain Study (HABS), Health & Aging Brain Study – Health Disparities (HABS-HD), and Wisconsin Registry for Alzheimer’s Prevention (WRAP). +46 moreeuropepmc +1 more sourceGenetic modifiers of APOE-ε4-associated cognitive decline. [PDF]
Nat CommunContreras AG, Walters S, Eissman JM, Archer DB, Regelson AN, Durant A, Clifton M, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez J, Bush WS, Kunkle BW, Cruchaga C, Naj AC, Gifford KA, Bilgel M, Kuzma AB, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer’s Disease Genetics Consortium (ADGC), Alzheimer’s Disease Sequencing Project (ADSP), Cuccaro ML, Pericak-Vance MA, Farrer LA, Wang LS, Schellenberg GD, Haines JL, Jefferson AL, Kukull WA, Keene CD, Saykin AJ, Thompson PM, Martin ER, Albert MS, Johnson SC, Engelman CD, Ferrucci L, Bennett DA, Barnes LL, Schneider JA, Sperling RA, Resnick SM, Crane PK, Dumitrescu L, Hohman TJ. +46 moreeuropepmc +1 more source
